FDA Approved: CERVIDIL — Supplemental Application (Ferring Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cervidil (dinoprostone) submitted by Ferring Pharmaceuticals, indicating an update in its regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Ripening
• Labor Induction

Drugs mentioned

• Cervidil (dinoprostone)

Snippet

SUPPL AP for CERVIDIL (DINOPROSTONE)